Maniar Shweta 4

What Happened

• Shweta Maniar, a director of Orthofix Medical Inc. (OFIX), received an award of 14,965 deferred stock units on 2026-06-10. The units were granted at $0.00 per unit (no cash paid at grant) and therefore the reported grant value is $0. This is an equity award, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-10 (Form 4 filed 2026-06-12; filing appears timely).
• Transaction type/code: Award/Grant (A).
• Amount: 14,965 deferred stock units granted at $0.00 per unit (reported value $0).
• Shares/units after transaction: 63,312 deferred stock units reported (14,965 new units plus 48,347 previously reported units per footnote).
• Footnotes:
  • F1 — These are deferred stock units that vest in full on the first anniversary of the grant, subject to continued service. Each unit represents a contingent right to one share; vested units will convert to common stock within 45 days of the recipient’s termination of service.
  • F2 — The filing includes 48,347 previously reported deferred stock units.
• No sale or exercise occurred; this is a compensation award rather than a purchase/sale.

Context

• Deferred stock units are compensation that convert to shares later (upon vesting and settlement), so this award does not indicate an immediate market purchase or sale. Such grants are routine for directors and reflect compensation arrangements rather than an outright insider investment signal.